Latest updates, from us and our ventures
Q4 2018
Some of the early signs of #Parkinsonsdisease include tremors, small handwriting and loss of smell. To learn more v… https://t.co/ekdiE61Nx5
— BlueRock (@BlueRockTx) December 11, 2018
Turning a messy problem into an eco-friendly solution. Discover how Mestic® is turning manure into high fashion an… https://t.co/hdbSoCZpuL
— Leaps by Bayer (@LeapsByBayer) December 10, 2018
Food for thought. If technology can give us clean power, can it also give us clean meat? #ReturnForHumanity… https://t.co/iY1GFEvljJ
— Leaps by Bayer (@LeapsByBayer) December 07, 2018
We are thrilled to deepen our relationship with the @McEwenInstitute @UHN to broaden and accelerate the development… https://t.co/2Lddpw4ZRF
— BlueRock (@BlueRockTx) December 06, 2018
This team from Japan have just used Stem Cells in a first-time revolutionary procedure for Parkinson's disease.… https://t.co/cR0y08SGbQ
— Leaps by Bayer (@LeapsByBayer) December 05, 2018
A successful #ASH18! Here is Casebia's @guenishi with poster "#Genomeediting via #NHEJ Targeted Integration Retains… https://t.co/csi6NnFLXD
— Casebia Therapeutics (@casebiatx) December 04, 2018
The cause of #Parkinsonsdisease is still unknown, so prevention remains a mystery. Research shows that regular aero… https://t.co/1vfBd4VTvE
— BlueRock (@BlueRockTx) December 04, 2018
#ASH18 starts tomorrow! We're thrilled to have had several posters accepted covering topics from #Treg cells to… https://t.co/ipme9jAkP5
— Casebia Therapeutics (@casebiatx) November 30, 2018
When we think of diverse agriculture, soil sensors and white space don't usually spring to mind. Dancing Crow Farm… https://t.co/90ZMjieePs
— Leaps by Bayer (@LeapsByBayer) November 30, 2018
Casebia’s Barbara Wan is at the #GeneEditSummit in #HongKong this week. https://t.co/Ir3iuCku7z
— Casebia Therapeutics (@casebiatx) November 29, 2018
November is #NationalCaregiversMonth. Thank you to all of the #Parkinsonsdisease #caregivers that have strived to m… https://t.co/aRp6tZcFHf
— BlueRock (@BlueRockTx) November 29, 2018
Read our statement on the use of germline #geneediting in China: https://t.co/DBU2r07OVC
— Casebia Therapeutics (@casebiatx) November 27, 2018
CEO Jim Burns on germline gene editing in Chinese twins: https://t.co/mD8IrvVHDv
— Casebia Therapeutics (@casebiatx) November 27, 2018
Today our team grows one stronger. Welcome Dr. Min Wang, our new Chief Legal and Administrative Officer. For more… https://t.co/A8naBFBRHS
— BlueRock (@BlueRockTx) November 26, 2018
.@biggreen, led by @kimbal is building learning gardens to educate children about healthy and sustainable communiti… https://t.co/LBuJvABrnC
— Leaps by Bayer (@LeapsByBayer) November 26, 2018
Wishing our American teammates, a happy #Thanksgiving! Today, BlueRock is #thankful for having such an inspiring t… https://t.co/G5BBPJcxCb
— BlueRock (@BlueRockTx) November 22, 2018
The Casebia Cambridge team collected non-perishable food and cash donations for the Preventative Food Pantry… https://t.co/8oAfGhObZ4
— Casebia Therapeutics (@casebiatx) November 21, 2018
Join the BlueRock team! We are looking for #scientists and #IT associates in our #Toronto office. Check out positio… https://t.co/uYonVydcgt
— BlueRock (@BlueRockTx) November 20, 2018
With stem cell treatment gaining momentum, the future is brimming with possibilities. Our venture @BlueRockTx has b… https://t.co/N0SV8cS0VN
— Leaps by Bayer (@LeapsByBayer) November 20, 2018
We are so proud of the BlueRock team! A group of talented and dedicated #innovators that are working together to de… https://t.co/z1ksAWvSBj
— BlueRock (@BlueRockTx) November 19, 2018
The current healthcare system leaves many rural medical centres under-resourced. This startup is making use of seco… https://t.co/jQQP69x1nP
— Leaps by Bayer (@LeapsByBayer) November 19, 2018
Members of our team were proud to attend the @2020VisionQuest Annual Peak Potential Dinner last night to support a… https://t.co/UC5iDyU2Fn
— Casebia Therapeutics (@casebiatx) November 18, 2018
During #ASH18, we & our collaborators @seattlechildren’s research institute will highlight findings around Conversi… https://t.co/tU9Cm6gUOc
— Casebia Therapeutics (@casebiatx) November 16, 2018
One million people will be living with #Parkinsonsdisease by 2020. We need a #treatment now more than ever. To lear… https://t.co/Zgp7Om5D0e
— BlueRock (@BlueRockTx) November 16, 2018
At the @MassBio Dinner on board #diversity this week w leaders from @jpmorgan, @NASA, #FrequencyTx @PolarisVC, Kale… https://t.co/p9DWJRbLuG
— Casebia Therapeutics (@casebiatx) November 15, 2018
Great discussion at #NYNJCEO hosted by @LeadingBiotech. Big thank you for getting the conversation started. https://t.co/79SHpPmhxs
— BlueRock (@BlueRockTx) November 14, 2018
We are pleased to announce that Abraham Scaria will be in #London Nov. 27th speaking at the #Ophthalmic Drugs Confe… https://t.co/iliwuS5lK2
— Casebia Therapeutics (@casebiatx) November 14, 2018
RT @EFIBconference: Gingko Bioworks and @Bayer created the JV @JoynBio to accelerate the uptake the use of #biology in #AgBiotech - partner…
— Joyn Bio (@JoynBio) November 13, 2018
RT @jmchauvet51: #EFIB2018 Matt McKnight CCO @GinkgoBioWorks presents @JoynBio a JV with @Bayer4Crops: great potential for fertilizing soil…
— Joyn Bio (@JoynBio) November 13, 2018
RT @AlkrizRTP: Mike Miile of @JoynBio talking about the Joint Venture between @Bayer4Crops and @GinkgoBioWorks @Ginkgoo to develop enhanced…
— Joyn Bio (@JoynBio) November 13, 2018
RT @LeapsByBayer: We are proud to announce that our joint venture @joynbio, in cooperation with @ginkgoo is making waves and has been named…
— Joyn Bio (@JoynBio) November 13, 2018
RT @SynBioBeta: What does the future hold for plant synthetic biology? Register now for the American Society of Plant Biologists' webinar…
— Joyn Bio (@JoynBio) November 13, 2018
Meet Theo Roth. The scientist making waves in the field with his revolutionary research into fighting diseases like… https://t.co/nEND3STYhD
— Leaps by Bayer (@LeapsByBayer) November 12, 2018
At #ASH18, we are pleased to explore several topics, including #GenomeEditing via NHEJ-Mediated Targeted Integratio… https://t.co/AzGHZGwnZC
— Casebia Therapeutics (@casebiatx) November 09, 2018
Robin Walker, our VP & Head of Legal, joined Derek Davis, @Harvard_Law, James Hackney, @NUSL, Yalonda Howze… https://t.co/glkPeAypJ2
— Casebia Therapeutics (@casebiatx) November 09, 2018
.@circulareconomy is leading some of the world's largest companies, accountable for 20% of global plastic packaging… https://t.co/vng1ILJ4X6
— Leaps by Bayer (@LeapsByBayer) November 09, 2018
Our venture @BlueRockTx have been working on some extraordinary cell therapy treatments. Take a look at their most… https://t.co/jzzYQnH5rR
— Leaps by Bayer (@LeapsByBayer) November 08, 2018
Thank you for meeting Casebia’s Head of Strategy & BD Peter Nell @EBDgroup’s Bio Partnering conference #BioEurope i… https://t.co/ucIuS4JuBW
— Casebia Therapeutics (@casebiatx) November 07, 2018
BlueRock Therapeutics to Participate at Upcoming Conferences https://t.co/za1rhMOlbs https://t.co/l90JSxTbT0
— BlueRock (@BlueRockTx) November 07, 2018
We are the 'Next Evolution in Health', addressing 10 key problems facing humanity and forming joint ventures that d… https://t.co/Il4KyWEaSz
— Leaps by Bayer (@LeapsByBayer) November 03, 2018
#ASH18 We are pleased to present three abstracts from our internal team and collaborators at @SeattleChildren’s hig… https://t.co/sAUipxYR5N
— Casebia Therapeutics (@casebiatx) November 02, 2018
#HappyHalloween from #TeamCasebia in San Francisco and Cambridge! And of course, congratulations to the @RedSox. Wh… https://t.co/wb4oKK70Ny
— Casebia Therapeutics (@casebiatx) October 31, 2018
We are very pleased to announce that Adel Nada, M.D., has joined us as Casebia's first Chief Medical Officer. Welco… https://t.co/JqWSvLWjzK
— Casebia Therapeutics (@casebiatx) October 31, 2018
Celebrating one year of #collaboration between @CasebiaTx and @SeattleChildren’s Research Institute to advance nove… https://t.co/7Kq8iVnzm2
— Casebia Therapeutics (@casebiatx) October 30, 2018
This time last year, @kimbal and Dr. Axel Bouchon, took to the stage as part of the LA17 @Summit to discuss future… https://t.co/uJZkaAGfzO
— Leaps by Bayer (@LeapsByBayer) October 29, 2018
We are proud to be included in this @NYT article that highlights our unique JV and our work to combine @Bayer’s pro… https://t.co/8UNLhe1DFw
— Casebia Therapeutics (@casebiatx) October 24, 2018
We are proud to announce that our joint venture @joynbio, in cooperation with @ginkgoo is making waves and has been… https://t.co/8Fdcl1jJ9R
— Leaps by Bayer (@LeapsByBayer) October 24, 2018
#CasebiaTx will be walking the walk this Saturday to @fightblindness in #Boston! Click here to sign up or donate:… https://t.co/VoImxAF0UP
— Casebia Therapeutics (@casebiatx) October 23, 2018
A wonderful event yesterday celebrating 50 years of @lcrboston fighting for #justice and #equity. Congratulations t… https://t.co/DVeJOfi4ev
— Casebia Therapeutics (@casebiatx) October 19, 2018
#October is #Blindness Awareness Month and members of our #Cambridge Team will be participating in the… https://t.co/14tO0NyOnU
— Casebia Therapeutics (@casebiatx) October 18, 2018
Insightful review by Bluestone and Tang regarding the clinical potential of regulatory T-cells (#Tregs) as a new th… https://t.co/KgNhrjd5Lx
— Casebia Therapeutics (@casebiatx) October 17, 2018
Similarly, Casebia and @seattlechildren are collaborating on developing gene edited Treg #therapeutics for… https://t.co/A3ujQhDsBn
— Casebia Therapeutics (@casebiatx) October 17, 2018
#CasebiaTx is in #Switzerland for the @ESGCT Annual Congress #ESGCT18 #ChangingModernMed https://t.co/RaONNgFgJt
— Casebia Therapeutics (@casebiatx) October 16, 2018
RT @CRISPRTX: $CRSP and @VertexPharma announce @FDA lifts clinical hold on investigational new drug application. Read the press release he…
— Casebia Therapeutics (@casebiatx) October 11, 2018
CEO Jim Burns speaking at the #Chardan Genetic Medicines conference in #NYC. https://t.co/2VmC1KGgme
— Casebia Therapeutics (@casebiatx) October 10, 2018
#CasebiaTx is dedicated to being at the forefront of efforts to develop a diverse & talented global workforce. We a… https://t.co/tvKjrSwBUa
— Casebia Therapeutics (@casebiatx) October 04, 2018
Congratulations @FrancesArnold for the #NobelPrize win! Her work as a scientist and engineer has “harnessed the pow… https://t.co/vjLonEf5pa
— Casebia Therapeutics (@casebiatx) October 04, 2018
We are pleased to announce that our CEO Jim Burns will be presenting at the Chardan #GeneticMedicines conference on… https://t.co/512mbvZJkN
— Casebia Therapeutics (@casebiatx) October 03, 2018
Congrats to our President and CEO, Emile Nuwaysir, on his election to serve as Vice Chairman of the @alliancerm, th… https://t.co/ARPPjrN3jz
— BlueRock (@BlueRockTx) October 03, 2018
Our CEO Jim Burns on a @alliancerm panel w/ James Brown @Aldevron, Stacy Coen @editasmed, Rachel Haurwitz… https://t.co/DV9auMIo6B
— Casebia Therapeutics (@casebiatx) October 03, 2018
Our VP and Head of Legal Robin Walker spoke on a @RopesGray #LifeSciences Quarterly panel this morning on the topic… https://t.co/xya7p8z8r8
— Casebia Therapeutics (@casebiatx) October 02, 2018
We are looking forward to attending @Alliancerm’s Cell & Gene Meeting on the Mesa. On Oct. 3, our CEO Dr. Emile Nuw… https://t.co/4owRO7CrXu
— BlueRock (@BlueRockTx) October 01, 2018